Chacotrace Injection (Activated Charcoal)

Adult dosage

Use an 18-gauge needle with localization devices or ultrasound to identify the tumor area to be removed and inject approximately 0.3 to 1 mL of this product subcutaneously at that area. During injection, maintain the syringe body horizontally, slowly withdrawing while moving the needle back and forth. Use only the minimal amount, do not administer more than 1 mL.

This drug should only be used by trained physicians and must be accurately marked only on the tumor area to be removed during surgery. All marked areas during surgery must be completely removed, and if not removed and left in the body for more than 6 months, inflammatory or immune reactions may occur. This drug should not be administered to patients with hypersensitivity to activated charcoal or dyes, or to pregnant or breastfeeding women. After use, side effects such as pain or a prickling sensation in the breast area, swelling, fever, or redness at the injection site may occur. This drug should only be injected subcutaneously and must not be administered by any other route. It should be used only when there is a clear surgical plan and only at the site of breast lesions. Administering beyond the necessary amount may cause the drug to spread to other tissues beyond the injection area. Ensure that the vial is shaken well before use as activated charcoal particles may block the needle, and injection should not be performed with excessive pressure. No safety studies have been conducted in pregnant women, nor has any research been done regarding use during breastfeeding. This drug is for single use only, and any remaining drug must be discarded. It should be stored out of reach of children. High doses administered intravenously may lead to pulmonary vessel accumulation of the drug, resulting in respiratory distress, therefore intravenous administration should be avoided.

Serious side effects

Shortness of breath or difficulty breathing, asthma attack, cough with accompanying fever indicating respiratory issues (attention regarding dyspnea mentioned)

Mild side effects

• Chest pain
• Pricking sensation
• Swelling at the injection site, fever, redness, pain

This drug may lose its effectiveness if exposed to air or moisture, so it must be stored in a sealed container. The storage temperature should be kept between 1 degree and 30 degrees Celsius at room temperature.

Appearance

An opaque black liquid in a colorless transparent vial, formulated as a suspension for injection.

Package unit

Vial - 3 milliliters/vial